ACIC Pharmaceuticals
Partners
Please contact us for a more in-depth understanding to meet your specific needs.
Featured Partners
AMSA S.p.A. was built from the ground in 1953 near Como, roughly 50 km from Milan.
Formosa Laboratories, Inc. produces APIs and UV-filters in its modern facilities near Taipei.
Icrom is a fully integrated company, devoted to the development and manufacturing of Active Ingredients and advanced intermediates for pharmaceutical use.
Polpharma is the largest Polish manufacturer of APIs. They are a world leader in the manufacture of hydrobisphosphonates (substances used for the treatment of osteoporosis).
Bioindustria was founded in 1932 and started with the production of National Formulary preparations.
Global Partnerships
API
Generic – Finished Dosage
With a tradition of 62 years in the pharmaceutical industry, Antibiotice is the Romanian manufacturer with the most complex production structure of finished formulations as well as the first worldwide manufacturer of Nystatin API. Antibiotice is active on more than 75 markets worldwide both with Nystatin API as well as with finished formulations – sterile powders for injections, capsules tablets, ointments and suppositories. All nine production facilities are GMP certified. Furthermore, the quality of the products is certified by the COS certificate and FDA approval for Nystatin and by the FDA approval for powders for injection.
Capabilities
- Development & Research
- Biotechnologies
- Regulatory Affairs
- Medicines for Human Use
- Medicines Veterinary Use
- Active Pharmaceutical Ingredients (API)
- Pharmacovigilance
- Finished Products
COSMA S. P. A. (founded 1977) and AMSA S. P. A. (founded 1953) are two chemical plants well known worldwide and especially appreciated in the western world and in the countries adhering to the PIC (Pharmaceutical Inspection Convention). They belong to the CFM Group, a private enterprise involved in chemistry and pharmaceuticals since 1949. Though being legally different enterprises they have been organized to optimize scale economy by the unification of many functions in the areas of management, quality and QA system, research, marketing and sales.
Capabilities
- Large-volume Active Pharmaceutical Ingredients (APIs)
- Small to medium Volume Active Pharmaceutical Ingredients (APIs)
- Custom Manufacturing
- Generic API
- Quality Control
- Quality Inspection
- Research
- Marketing & Sales
Formosa Laboratories Inc. founded in Taiwan since 1995 started with API business and has been serving customers worldwide. As an established API manufacturer receiving GMP inspections from regulatory authorities around the world, Formosa now provides CDMO service extending from APIs and ADCs (Antibody Drug Conjugates) to cytotoxic and non-cytotoxic injectables of aseptic liquid filling and lyophilization. Formosa Laboratories is able to offer full-service GMP manufacturing for drug substance, ADCs and drug product with its API and injectable facilities that accommodates small molecules, biologics and ADCs from pilot scale to commercial scale, all under regulated or cytotoxic control and GMP compliance.
Capabilities
- Active Pharmaceutical Ingredients (API)
- Contract Development & Manufacturing Organization (CDMO)
- Antibody Drug Conjugates (ADCs)
- Injectable Manufacturing
- Commercial Production
- High Potency API (HPAPI)
- Analytical Instrument
- Quality & Compliance
ICROM is an Italian chemical-pharmaceutical Company specialized in contract development and GMP manufacturing of Potent and non-Potent APIs. A reliable partner with a strong know-how, that is present and active on the worldwide pharmaceutical market since more than 40 years, and that with passion and professionalism were able to diversify over the years its business model and portfolio, strongly investing in research & development and innovative products. With four state-of-the-art manufacturing units approved by AIFA, USFDA, PMDA, KFDA and high-quality standards, ICROM is the partner of choice for custom synthesis, contract manufacturing, niche generics, difficult-to-make products.
Capabilities
- Custom Synthesis
- Contract Manufacturing
- Multi-scale GMP Production
- High Potency APIs
- Research & Development
Polpharma is the largest Polish manufacturer of APIs, i.e. active substances for the manufacture of finished drug forms. Thanks to competitive manufacturing costs, excellent product quality and environment-friendly processes, they are in the position of being a world leader in the manufacture of hydrobisphosphonates (substances used for the treatment of osteoporosis).
Polypharma’s broad and varied portfolio and years of experience allow them to offer modern products and solutions to pharmaceutical companies worldwide. The total capacity of their reactors for substance synthesis is 350,000 litres. Their manufacturing facilities are subject to rigorous inspections by the US Food and Drug Administration (FDA). All FDA inspections (in 2004, 2009, 2012 and 2015) conducted so far have resulted in no objections being raised.
Capabilities
- Active Pharmaceutical Ingredients (APIs)
- Manufacturing
- R&D Lab
- QA & Regulatory
Trifarma means excellence in products and service. As an international organization manufacturing and supplying APIs, Trifarma is strongly committed to excel in quality, tapping into a long-lasting tradition in chemistry, started in 1958. Delivering the best to our customers is our focus. Integrity, respect for people, innovation and teamwork are our driving values. Their shareholders also control the Chennai based Alchymars ICM SM and the overall Group’s manufacturing capacity is supported by four sites with fully equipped infrastructure facilities – two plants in Italy and two in India – operating in cGMP. We offer a large variety of molecules: Phenothiazines, Steroids, Diphosphonates, Clindamycin HCl & Phosphate and other APIs for injectable, derma, and ophtalmic use – distributed worldwide: 37% to North America, 10% to LATAM, 27% to EU, 22% to ASIA, and 4% ROW.
Capabilities
- Active Pharmaceutical Ingredients (APIs)
- Manufacturing
- R&D Lab
- QA & Regulatory
Fermic started its activity in 1968 and today is one of the largest fermentation companies in Latin America. Fermic is a US FDA approved fermentation manufacturer of APIs. Our best product is potassium clavulanate, sold as oral and sterile mixtures. We can also manufacture fermentation products for third parties.
Capabilities
- API Manufacturing
- Specialty in Fermentation
- USA FDA-GMP Approved Fermentation & Synthesis Plant
- Anti Infectives
- Astaxanthin-biocolorant and Antioxidant
- Custom Manufacturing
Bioindustria was founded in 1932 and started with the production of National Formulary preparations. During Second World War the facility was heavily damaged and, after the end of the war, was reconstructed and started the manufacture of organ extracts and enzymes for its brand pharmaceuticals. At the same time it developed a successful line of original chemical and biological brand drugs. In the sixties a new chemical plant was built with the purpose to supply the active principles to its Pharmaceutical Specialities.
Capabilities
- Injectables
- Pharma Products
- API
- R&D
- Quality Control
- Quality System
